\-\ Texto\\:\\ \ \(0\)\
\-\ unknow\\ exam\\.\ \(0\)\
\-\ labs\\ significant\\ for\\:\ \(0\)\
\-\ hemoglobin\\ a1c\\ 6\\.0\\-8\\.0\\ over\\ past\\ 6months\ \(0\)\
\-\ wbc\\ 13\\.0\\-23\\.9\\ over\\ past\\ month\ \(0\)\
\-\ wound\\ cultures\\ negative\\.\ \(0\)\
\-\ for\\ patients\\ with\\ severe\\ joint\\ destruction\\,\\ chronic\\ ulcers\\,\\ and\\ possibly\\ osteomyelitis\\,\\ amputations\\ are\\ typically\\ involved\\ to\\ prevent\\ systemic\\ infection\\.\\ \\ upon\\ presentation\\ iv\\ vancomycin\\ was\\ begun\\ on\\ this\\ patient\\,\\ but\\ was\\ later\\ dicontinued\\ after\\ all\\ wound\\ cultures\\ were\\ negative\\.\\ \\ further\\ follow\\ up\\ is\\ unknown\\.\ \(0\)\
\-\ two\\ images\\ are\\ submitted\\.\\ \\ the\\ one\\ on\\ the\\ right\\ is\\ 6\\ months\\ prior\\ to\\ the\\ one\\ on\\ the\\ left\\.\\ \\ interval\\ worsening\\ of\\ the\\ joint\\ destruction\\ is\\ evident\\.\\ \\ please\\ see\\ the\\ specific\\ captions\\ for\\ the\\ findings\\.\\ \\ however\\,\\ typical\\ radiographic\\ findings\\ include\\:\\ joint\\ destruction\\,\\ disorganization\\,\\ subluxation\\,\\ dislocation\\,\\ heterotopic\\ bone\\ formation\\,\\ soft\\ tissue\\ swelling\\,\\ sclerosis\\,\\ periostitis\\.\\ \\ most\\ of\\ these\\ are\\ found\\ in\\ the\\ images\\ submitted\\.\\ \\ please\\ see\\ captions\\ for\\ specific\\ findings\\ for\\ each\\ image\\.\ \(0\)\
\-\ charcot\\ joint\ \(0\)\
\-\ the\\ term\\ \\"charcot\\ joint\\"\\ is\\ a\\ general\\ term\\ used\\ to\\ describe\\ severe\\ articular\\ abnormalities\\ related\\ to\\ neurologic\\ deficits\\,\\ regardless\\ of\\ the\\ primary\\ cause\\.\\ \\ the\\ following\\ is\\ a\\ list\\ of\\ some\\ of\\ the\\ causes\\.\ \(0\)\
\-\ 1\\)\\ trauma\ \(1\)\
\-\ 2\\)\\ infection\ \(2\)\
\-\ 3\\)\\ neuropathic\\ osteoarthropathies\\:\ \(1\)\
\-\ \\ \\ \\ a\\)\\ central\\ nervous\\ system\\ disorders\\ \\(syphilis\\,\\ syringomyelia\\,\\ meningo\\-myelocele\\,\\ multiple\\ sclerosis\\,\\ charcot\\-marie\\-tooth\\ disease\\)\ \(0\)\
\-\ \\ \\ \\ b\\)\\ congenital\\ vascular\\ anomalies\ \(0\)\
\-\ \\ \\ \\ c\\)\\ other\\ causes\\ of\\ cord\\ compression\\,\\ injury\\,\\ or\\ degeneration\\ \ \(0\)\
\-\ \\ \\ \\ d\\)\\ peripheral\\ neuropathies\\ including\\ diabetes\\ mellitus\\,\\ alcoholism\\,\\ amyloidosis\\,\\ infection\\,\\ pernicious\\ anemia\\,\\ trauma\\,\\ and\\ intra\\-articular\\ or\\ systemic\\ administration\\ of\\ steroids\\.\ \(0\)\
\-\ 55\\ yo\\ female\\ with\\ a\\ known\\ long\\ history\\ of\\ diabetes\\ mellitus\\ who\\ presented\\ with\\ acute\\ on\\ chronic\\ foot\\ swelling\\ and\\ draining\\ ulcer\\.the\\ patient\\ has\\ had\\ a\\ long\\ history\\ of\\ poorly\\ controlled\\ diabetes\\ and\\ peripheral\\ neuropathy\ \(0\)\
\-\ diabetes\\ is\\ the\\ leading\\ cause\\ of\\ neuropathic\\ osteoarthropathy\\.\\ \\ diabetic\\ neuropathic\\ osteoarthropathy\\ typically\\ appears\\ in\\ patients\\ with\\ long\\ standing\\ poorly\\ controlled\\ diabetes\\.\\ \\ in\\ addition\\ to\\ the\\ progressive\\ loss\\ of\\ sensation\\ and\\ repetitive\\ trauma\\,\\ the\\ findings\\ relate\\ in\\ part\\ to\\ a\\ neurally\\ initiated\\ vascular\\ reflex\\ that\\ leads\\ to\\ increased\\ blood\\ flow\\.\\ \\ the\\ fractures\\,\\ subluxations\\,\\ and\\ joint\\ destruction\\ may\\ represent\\ the\\ terminal\\ event\\ occuring\\ when\\ repetitive\\ mechanical\\ trauma\\ is\\ applied\\ to\\ a\\ site\\ containing\\ bones\\ made\\ weak\\ and\\ vulnerable\\ by\\ hypervascularity\\.\\ \\ this\\ particular\\ patient\\ has\\ had\\ long\\ standing\\ poorly\\ controlled\\ diabetes\\,\\ evident\\ by\\ her\\ hba1c\\ levels\\,\\ and\\ known\\ peripheral\\ diabetic\\ neuropathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ diabetes\\:\\ 0\\.28029045021295756\ \(0\)\
\-\ joint\\:\\ 0\\.20220317343967084\ \(0\)\
\-\ charcot\\:\\ 0\\.20207719216154213\ \(0\)\
\-\ destruction\\:\\ 0\\.18650345857031939\ \(0\)\
\-\ the\\:\\ 0\\.1836874256479003\ \(0\)\
\-\ neuropathic\\:\\ 0\\.17967467573840123\ \(0\)\
\-\ controlled\\:\\ 0\\.15988658229184669\ \(0\)\
\-\ poorly\\:\\ 0\\.13857798309260116\ \(0\)\
\-\ long\\:\\ 0\\.1356519725069161\ \(0\)\
\-\ captions\\:\\ 0\\.13471812810769476\ \(0\)\
\-\ osteoarthropathy\\:\\ 0\\.12868479698006424\ \(0\)\
\-\ trauma\\:\\ 0\\.11880732148150996\ \(0\)\
\-\ repetitive\\:\\ 0\\.11690799048726641\ \(0\)\
\-\ mellitus\\:\\ 0\\.1138615068975785\ \(0\)\
\-\ neuropathy\\:\\ 0\\.11174952267424877\ \(0\)\
\-\ of\\:\\ 0\\.11009277989476726\ \(0\)\
\-\ peripheral\\:\\ 0\\.10971422887181449\ \(0\)\
\-\ diabetic\\:\\ 0\\.10856349642677687\ \(0\)\
\-\ submitted\\:\\ 0\\.10815126813327149\ \(0\)\
\-\ wound\\:\\ 0\\.10289120718146103\ \(0\)\
\-\ to\\:\\ 0\\.10228494905422453\ \(0\)\
\-\ findings\\:\\ 0\\.10096424335608431\ \(0\)\
\-\ is\\:\\ 0\\.09804076910726567\ \(0\)\
\-\ cultures\\:\\ 0\\.09634429991590146\ \(0\)\
\-\ standing\\:\\ 0\\.09512124816524671\ \(0\)\
\-\ articular\\:\\ 0\\.09343015007098585\ \(0\)\
\-\ infection\\:\\ 0\\.09267976990853637\ \(0\)\
\-\ systemic\\:\\ 0\\.09076881002749441\ \(0\)\
\-\ evident\\:\\ 0\\.08791659855515023\ \(0\)\
\-\ please\\:\\ 0\\.08580461433182049\ \(0\)\
\-\ and\\:\\ 0\\.08454439409049312\ \(0\)\
\-\ unknow\\:\\ 0\\.0817885931475193\ \(0\)\
\-\ 6months\\:\\ 0\\.0817885931475193\ \(0\)\
\-\ dicontinued\\:\\ 0\\.0817885931475193\ \(0\)\
\-\ osteoarthropathies\\:\\ 0\\.0817885931475193\ \(0\)\
\-\ neurally\\:\\ 0\\.0817885931475193\ \(0\)\
\-\ term\\:\\ 0\\.08021195724149872\ \(0\)\
\-\ specific\\:\\ 0\\.07750924671584158\ \(0\)\
\-\ for\\:\\ 0\\.07750506660824659\ \(0\)\
\-\ causes\\:\\ 0\\.07728922995512309\ \(0\)\
\-\ pernicious\\:\\ 0\\.07557413322283678\ \(0\)\
\-\ relate\\:\\ 0\\.07557413322283678\ \(0\)\
\-\ hba1c\\:\\ 0\\.07557413322283678\ \(0\)\
\-\ sclerosis\\:\\ 0\\.07285591487066057\ \(0\)\
\-\ neuropathies\\:\\ 0\\.0719389072046631\ \(0\)\
\-\ vulnerable\\:\\ 0\\.0719389072046631\ \(0\)\
\-\ typically\\:\\ 0\\.0718057174524661\ \(0\)\
\-\ a1c\\:\\ 0\\.07055685841471464\ \(0\)\
\-\ amputations\\:\\ 0\\.07055685841471464\ \(0\)\
\-\ disorganization\\:\\ 0\\.07055685841471464\ \(0\)\
\-\ cause\\:\\ 0\\.06968180696263065\ \(0\)\
\-\ subluxations\\:\\ 0\\.06935967329815428\ \(0\)\
\-\ swelling\\:\\ 0\\.06884331514330842\ \(0\)\
\-\ hypervascularity\\:\\ 0\\.06830368118648941\ \(0\)\
\-\ vascular\\:\\ 0\\.06752748236300404\ \(0\)\
\-\ past\\:\\ 0\\.0665802673388079\ \(0\)\
\-\ known\\:\\ 0\\.06622282412009332\ \(0\)\
\-\ severe\\:\\ 0\\.06475130587323286\ \(0\)\
\-\ begun\\:\\ 0\\.06434239849003212\ \(0\)\
\-\ occuring\\:\\ 0\\.06434239849003212\ \(0\)\
\-\ see\\:\\ 0\\.0636280492434269\ \(0\)\
\-\ negative\\:\\ 0\\.06332441024900931\ \(0\)\
\-\ alcoholism\\:\\ 0\\.06314521337347176\ \(0\)\
\-\ periostitis\\:\\ 0\\.06260167905162266\ \(0\)\
\-\ syringomyelia\\:\\ 0\\.06260167905162266\ \(0\)\
\-\ regardless\\:\\ 0\\.06208922126180689\ \(0\)\
\-\ on\\:\\ 0\\.06178410606504667\ \(0\)\
\-\ vancomycin\\:\\ 0\\.06114460412916486\ \(0\)\
\-\ chronic\\:\\ 0\\.060713899398511295\ \(0\)\
\-\ applied\\:\\ 0\\.06029009399131826\ \(0\)\
\-\ syphilis\\:\\ 0\\.05989155857946707\ \(0\)\
\-\ nervous\\:\\ 0\\.05950998735529807\ \(0\)\
\-\ weak\\:\\ 0\\.05879235881542803\ \(0\)\
\-\ one\\:\\ 0\\.0585633949862962\ \(0\)\
\-\ are\\:\\ 0\\.05821918685132559\ \(0\)\
\-\ describe\\:\\ 0\\.058127938565349604\ \(0\)\
\-\ patients\\:\\ 0\\.05754132991792261\ \(0\)\
\-\ over\\:\\ 0\\.056875375463771\ \(0\)\
\-\ list\\:\\ 0\\.05665486797314456\ \(0\)\
\-\ amyloidosis\\:\\ 0\\.05638721912694015\ \(0\)\
\-\ initiated\\:\\ 0\\.055874761337124386\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.05407563406663574\ \(0\)\
\-\ heterotopic\\:\\ 0\\.05407563406663574\ \(0\)\
\-\ ulcers\\:\\ 0\\.05387415209281747\ \(0\)\
\-\ terminal\\:\\ 0\\.05257789889074551\ \(0\)\
\-\ leads\\:\\ 0\\.051598864938429724\ \(0\)\
\-\ subluxation\\:\\ 0\\.05129491818630865\ \(0\)\
\-\ event\\:\\ 0\\.0510009387176101\ \(0\)\
\-\ had\\:\\ 0\\.050962522780626206\ \(0\)\
\-\ in\\:\\ 0\\.05089075137340952\ \(0\)\
\-\ mechanical\\:\\ 0\\.05071629352410673\ \(0\)\
\-\ reflex\\:\\ 0\\.05057728964643861\ \(0\)\
\-\ particular\\:\\ 0\\.049912869396360186\ \(0\)\
\-\ patient\\:\\ 0\\.04990263075513458\ \(0\)\
\-\ draining\\:\\ 0\\.04953663641022633\ \(0\)\
\-\ anomalies\\:\\ 0\\.04882846023867006\ \(0\)\
\-\ each\\:\\ 0\\.04849430092041775\ \(0\)\
\-\ possibly\\:\\ 0\\.04806728828870592\ \(0\)\
\-\ degeneration\\:\\ 0\\.047560624082623355\ \(0\)\
\-\ images\\:\\ 0\\.047313970475868855\ \(0\)\
\-\ anemia\\:\\ 0\\.04698815920803245\ \(0\)\
\-\ prevent\\:\\ 0\\.04689620383254493\ \(0\)\
\-\ has\\:\\ 0\\.04672115149208603\ \(0\)\
\-\ interval\\:\\ 0\\.046277643378186496\ \(0\)\
\-\ containing\\:\\ 0\\.04594244282301122\ \(0\)\
\-\ part\\:\\ 0\\.04569901871598458\ \(0\)\
\-\ leading\\:\\ 0\\.045462029485795134\ \(0\)\
\-\ disorders\\:\\ 0\\.04515548439413548\ \(0\)\
\-\ steroids\\:\\ 0\\.04493226363941648\ \(0\)\
\-\ dislocation\\:\\ 0\\.0443628297217561\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.04409112497386969\ \(0\)\
\-\ deficits\\:\\ 0\\.043958299277575115\ \(0\)\
\-\ 55\\:\\ 0\\.043958299277575115\ \(0\)\
\-\ sensation\\:\\ 0\\.043827412711928346\ \(0\)\
\-\ by\\:\\ 0\\.04343646291818949\ \(0\)\
\-\ represent\\:\\ 0\\.04255743501269336\ \(0\)\
\-\ addition\\:\\ 0\\.041395561365628254\ \(0\)\
\-\ site\\:\\ 0\\.041248178805419526\ \(0\)\
\-\ bones\\:\\ 0\\.041151252774753885\ \(0\)\
\-\ general\\:\\ 0\\.04105536340599785\ \(0\)\
\-\ involved\\:\\ 0\\.04100780058614602\ \(0\)\
\-\ neurologic\\:\\ 0\\.04086660758125052\ \(0\)\
\-\ administration\\:\\ 0\\.0407276037035824\ \(0\)\
\-\ formation\\:\\ 0\\.04054555540798949\ \(0\)\
\-\ levels\\:\\ 0\\.04054555540798949\ \(0\)\
\-\ foot\\:\\ 0\\.04041140471789734\ \(0\)\
\-\ upon\\:\\ 0\\.040235603584970685\ \(0\)\
\-\ with\\:\\ 0\\.04005765829255299\ \(0\)\
\-\ typical\\:\\ 0\\.039524673267687244\ \(0\)\
\-\ made\\:\\ 0\\.03944462299914555\ \(0\)\
\-\ progressive\\:\\ 0\\.039169945089064705\ \(0\)\
\-\ history\\:\\ 0\\.039079078940927076\ \(0\)\
\-\ worsening\\:\\ 0\\.039054754161690935\ \(0\)\
\-\ system\\:\\ 0\\.039016683741365486\ \(0\)\
\-\ related\\:\\ 0\\.038865998336943625\ \(0\)\
\-\ unknown\\:\\ 0\\.03875462335792079\ \(0\)\
\-\ used\\:\\ 0\\.038287373674741706\ \(0\)\
\-\ radiographic\\:\\ 0\\.03794382319478071\ \(0\)\
\-\ cord\\:\\ 0\\.03791018123967813\ \(0\)\
\-\ fractures\\:\\ 0\\.037810006225278754\ \(0\)\
\-\ compression\\:\\ 0\\.037451986694906216\ \(0\)\
\-\ appears\\:\\ 0\\.037451986694906216\ \(0\)\
\-\ abnormalities\\:\\ 0\\.037046517889688726\ \(0\)\
\-\ congenital\\:\\ 0\\.03674663807822036\ \(0\)\
\-\ later\\:\\ 0\\.036600377566796995\ \(0\)\
\-\ including\\:\\ 0\\.036600377566796995\ \(0\)\
\-\ iv\\:\\ 0\\.036542534975742835\ \(0\)\
\-\ wbc\\:\\ 0\\.036147760552766674\ \(0\)\
\-\ was\\:\\ 0\\.03564759750426864\ \(0\)\
\-\ or\\:\\ 0\\.03558339203711273\ \(0\)\
\-\ labs\\:\\ 0\\.0354322542925882\ \(0\)\
\-\ presentation\\:\\ 0\\.03520590248169901\ \(0\)\
\-\ this\\:\\ 0\\.03514722665499054\ \(0\)\
\-\ central\\:\\ 0\\.03415267028094254\ \(0\)\
\-\ flow\\:\\ 0\\.034064771826745825\ \(0\)\
\-\ injury\\:\\ 0\\.03335050810977703\ \(0\)\
\-\ further\\:\\ 0\\.033310213343004734\ \(0\)\
\-\ found\\:\\ 0\\.033091772248216744\ \(0\)\
\-\ image\\:\\ 0\\.03270774906983716\ \(0\)\
\-\ some\\:\\ 0\\.03217859949858351\ \(0\)\
\-\ yo\\:\\ 0\\.0319511679537838\ \(0\)\
\-\ her\\:\\ 0\\.0319511679537838\ \(0\)\
\-\ primary\\:\\ 0\\.031447351678386574\ \(0\)\
\-\ loss\\:\\ 0\\.031158114643289807\ \(0\)\
\-\ month\\:\\ 0\\.03111080281573976\ \(0\)\
\-\ when\\:\\ 0\\.030893256636178788\ \(0\)\
\-\ following\\:\\ 0\\.030680864322693277\ \(0\)\
\-\ all\\:\\ 0\\.03044413583704035\ \(0\)\
\-\ include\\:\\ 0\\.030429545808572128\ \(0\)\
\-\ two\\:\\ 0\\.030371421971187706\ \(0\)\
\-\ however\\:\\ 0\\.030270603248393802\ \(0\)\
\-\ presented\\:\\ 0\\.029823628673193176\ \(0\)\
\-\ months\\:\\ 0\\.029769291715871248\ \(0\)\
\-\ blood\\:\\ 0\\.02970183037037749\ \(0\)\
\-\ significant\\:\\ 0\\.02952877018390318\ \(0\)\
\-\ who\\:\\ 0\\.02892956811878448\ \(0\)\
\-\ these\\:\\ 0\\.028880374192809276\ \(0\)\
\-\ prior\\:\\ 0\\.028614529175457315\ \(0\)\
\-\ bone\\:\\ 0\\.027905147366674755\ \(0\)\
\-\ acute\\:\\ 0\\.02766634081372399\ \(0\)\
\-\ increased\\:\\ 0\\.02765563565362807\ \(0\)\
\-\ follow\\:\\ 0\\.027570451444967947\ \(0\)\
\-\ soft\\:\\ 0\\.027227379065021214\ \(0\)\
\-\ tissue\\:\\ 0\\.02682840019722755\ \(0\)\
\-\ most\\:\\ 0\\.026616301541076793\ \(0\)\
\-\ other\\:\\ 0\\.026559316790878758\ \(0\)\
\-\ were\\:\\ 0\\.02636267498575218\ \(0\)\
\-\ exam\\:\\ 0\\.02574534954351983\ \(0\)\
\-\ may\\:\\ 0\\.025736708029101284\ \(0\)\
\-\ up\\:\\ 0\\.02529845380465678\ \(0\)\
\-\ but\\:\\ 0\\.025290232281370756\ \(0\)\
\-\ multiple\\:\\ 0\\.02501509390547361\ \(0\)\
\-\ after\\:\\ 0\\.024810247706832614\ \(0\)\
\-\ female\\:\\ 0\\.02467879671149627\ \(0\)\
\-\ that\\:\\ 0\\.022194090405817442\ \(0\)\
\-\ disease\\:\\ 0\\.021467962634187647\ \(0\)\
\-\ left\\:\\ 0\\.01744595055513317\ \(0\)\
\-\ right\\:\\ 0\\.01695597959498531\ \(0\)\
